SCHEMBL43661

SCHEMBL43661

CN[C@H](C(=O)O)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL716843 1.00 SMN1; SMN2 (0.41)
SCHEMBL161931 1.00
SCHEMBL43660 1.00
Hydrochloric Acid SCHEMBL3947878 0.97 SMN1; SMN2 (0.39)
Hydrochloric Acid SCHEMBL6780690 0.97 SMN1; SMN2 (0.39)
Hydrochloric Acid SCHEMBL3947884 0.97 SMN1; SMN2 (0.39)
Valine SCHEMBL28845417 0.86 SLC7A5 (0.65)
Trifluoroacetic Acid SCHEMBL30405351 0.86 MMP1 (0.36)
SCHEMBL5490834 0.83 TP53 (0.36)
SCHEMBL5490842 0.83 TP53 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 12274 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122028793-A Fungicidal compositions 先正达农作物保护股份公司 2026-05-12 CN claimed
EP-4720086-A1 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR Zealand Pharma A/S (DK) 2026-04-08 EP claimed
EP-4720087-A1 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR Zealand Pharma A/S (DK) 2026-04-08 EP claimed
US-20260083866-A1 COMPOSITIONS TARGETING ENDOTHELIAL CELLS AND USES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2026-03-26 US claimed
US-12575567-B2 Fungicidal compositions SYNGENTA CROP PROTECTION AG (CH) 2026-03-17 US claimed
US-20260035408-A1 WKYMVm peptide analogues having six residues and uses thereof RESEARCH & BUSINESS FOUND SUNGKYUNKWAN UNIV (KR) 2026-02-05 US claimed
US-12527322-B2 Fungicidal compositions SYNGENTA CROP PROTECTION AG (CH) 2026-01-20 US claimed
EP-4663786-A1 A METHOD FOR RECOVERING A COMPONENT FROM A PEROVSKITE STRUCTURE Saule S.A. (PL) 2025-12-17 EP claimed
EP-4658676-A2 ANTI-CDH17 ANTIBODIES AND USE OF THE SAME Bighat Biosciences, Inc. (US) 2025-12-10 EP claimed
EP-4642492-A1 AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES Hangzhou Seehe Biotechnology Co., Ltd (CN) 2025-11-05 EP claimed
EP-0352092-B1 Novel antibiotics R106 TAKARA SHUZO CO (JP) 1993-10-27 EP claimed
EP-0300784-B1 PEPTIDES BTG INTERNATIONAL LIMITED (GB) 1993-09-01 EP claimed
US-4997648-A Bactericide, antiinflammatory, immunosuppressive BRITISH TECHNOLOGY GROUP LIMITED (GB) 1991-03-05 US claimed
EP-0352092-A2 Novel antibiotics R106 TAKARA SHUZO CO. LTD. (JP) 1990-01-24 EP claimed
EP-0300784-A2 Peptides BTG INTERNATIONAL LIMITED (GB) 1989-01-25 EP claimed
EP-0300785-A2 Cyclosporins BTG INTERNATIONAL LIMITED (GB) 1989-01-25 EP claimed
US-4522812-A Novel physiologically active substance K-4, a process for preparation thereof and a pharmaceutical composition containing the same KYOWA HAKKO KOGYO CO., LTD. (JP) 1985-06-11 US claimed
US-4336249-A MYCOPLANECIN PRODUCT CULTIVATED FORM ACTINOPLANES SANKYO COMPANY LIMITED (JP) 1982-06-22 US claimed
US-4118482-A Process for treating neoplastic disease with azetomicins THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1978-10-03 US claimed
US-4053460-A ACTINOMYCIN ANTIBIOTIC ANALOGUES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1977-10-11 US claimed